[EN] ALDO-KETO REDUCTASE SUBFAMILY 1C3 (AKR1C3) INHIBITORS<br/>[FR] INHIBITEURS DE LA SOUS-FAMILLE 1C3 D'ALDO-CÉTO RÉDUCTASE (AKR1C3)
申请人:GTX INC
公开号:WO2013142390A1
公开(公告)日:2013-09-26
The present invention relates to a novel class of AKR1C3 inhibitors, to compositions containing them, to methods for their preparation, and to methods of use thereof. The AKR1C3 inhibitors may be useful in the treatment of, for example, prostate cancer, benign prostate hyperplasia (BPH), lung cancer, acne, seborrhea, hirsutism, baldness, alopecia, precocious puberty, adrenal hypertrophy, polycystic ovary syndrome, breast cancer, uterine cancer, uterine fibroids, endometriosis, myeloma and leiomyoma.